RAMNEET BASRA: Open Payments
NPI 1457874893 · LINCOLN, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$624 in 18 payments from 9 companies in 2025. Trend: 2023 $592 · 2024 $370 · 2025 $624
Food & beverage: $557Education: $67
| Company | Payments | Amount |
|---|---|---|
| Ortho Dermatologics, a division of Bausch Health US, LLC | 2 | $133 |
| Incyte Corporation | 1 | $122 |
| Novartis Pharmaceuticals Corporation | 4 | $81 |
| Regeneron Healthcare Solutions, Inc. | 2 | $69 |
| Janssen Biotech, Inc. | 1 | $67 |
| ABBVIE INC. | 3 | $49 |
| UCB, Inc. | 2 | $44 |
| LEO Pharma Inc. | 2 | $44 |
| Biofrontera Inc. | 1 | $14 |
Products named: Opzelura, Cabtreo, COSENTYX, DUPIXENT, TREMFYA, Bimzelx, ADBRY, RINVOQ.
Industry payments across CA — which companies pay providers there.
